Article
|
Open Access
Featured
-
-
Article |
IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells
- Kai Zhang
- , Wenhao Hu
- & Yi Zhang
-
Article
| Open AccessA spectroscopic liquid biopsy for the earlier detection of multiple cancer types
- James M. Cameron
- , Alexandra Sala
- & Matthew J. Baker
-
Article
| Open AccessEfficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer
- Xuhui Dong
- , Jiqiang Fan
- & Yuncheng Bei
-
Review Article
| Open AccessHead and neck cancer patient-derived tumouroid cultures: opportunities and challenges
- B. W. M. Thilini J. Basnayake
- , Paul Leo
- & Chamindie Punyadeera
-
Article
| Open AccessTh2 cells inhibit growth of colon and pancreas cancers by promoting anti-tumorigenic responses from macrophages and eosinophils
- Damian Jacenik
- , Ioannis Karagiannidis
- & Ellen J. Beswick
-
Article |
Capecitabine induces hand-foot syndrome through elevated thymidine phosphorylase-mediated locoregional toxicity and GSDME-driven pyroptosis that can be relieved by tipiracil
- Bingxue Yang
- , Xinran Xie
- & Shiyi Zhang
-
Article |
RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminoma
- Christine Hjorth Andreassen
- , Mette Lorenzen
- & Martin Blomberg Jensen
-
Article |
miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome
- Maria-Alexandra Papadimitriou
- , Aristea-Maria Papanota
- & Andreas Scorilas
-
Comment |
Myeloma-bone marrow adipocyte axis in tumour survival and treatment response
- Abbas Jafari
- , Heather Fairfield
- & Michaela R. Reagan
-
Article
| Open Access5-Aminosalicylic acid inhibits stem cell function in human adenoma-derived cells: implications for chemoprophylaxis in colorectal tumorigenesis
- Steven William Dixon
- , Tracey Jane Collard
- & Ann Caroline Williams
-
Article |
A Wnt-mediated phenotype switch along the epithelial–mesenchymal axis defines resistance and invasion downstream of ionising radiation in oral squamous cell carcinoma
- Fatemeh Zolghadr
- , Nigel Tse
- & Naisana Seyedasli
-
Article
| Open AccessPharmaceutical immunoglobulin G impairs anti-carcinoma activity of oxaliplatin in colon cancer cells
- Yuru Shang
- , Xianbin Zhang
- & Michael Linnebacher
-
Article
| Open AccessTumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer
- Moran Yang
- , Guodong Zhang
- & Congjian Xu
-
Article
| Open AccessDirect therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer
- Mei Gao
- , Miranda Lin
- & Joseph Kim
-
Article
| Open AccessCombinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer
- Viswanath Gunda
- , Benjamin Gigliotti
- & Sareh Parangi
-
Translational Therapeutics
| Open AccessPotentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy
- K J Gash
- , A C Chambers
- & M G Thomas
-
Translational Therapeutics
| Open AccessImpact of CTLA-4 blockade in conjunction with metronomic chemotherapy on preclinical breast cancer growth
- Karla Parra
- , Paloma Valenzuela
- & Giulio Francia
-
Commentary
| Open AccessA new roadmap to improve translation of imaging biomarkers
- Michael Skwarski
- & Geoff S Higgins
-
Mini Review
| Open AccessTargeting LKB1 in cancer – exposing and exploiting vulnerabilities
- M Momcilovic
- & D B Shackelford
-
Translational Therapeutics
| Open AccessBRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts
- I Lohse
- , A Borgida
- & D W Hedley
-
Translational Therapeutics
| Open AccessTumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules
- J Murray
- , H Thomas
- & N J Curtin
-
Translational Therapeutics
| Open AccessAurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer
- A Azzariti
- , G Bocci
- & A Paradiso
-
Translational Therapeutics
| Open AccessTargeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease
- B H Kang
- , M Tavecchio
- & D C Altieri
-
Translational Therapeutics
| Open AccessCentral nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699
- R A Daniel
- , A L Rozanska
- & N J Curtin
-
Translational Therapeutics
| Open AccessActivity of irinotecan and temozolomide in the presence of O6-methylguanine-DNA methyltransferase inhibition in neuroblastoma pre-clinical models
- W Cai
- , N V Maldonado
- & N Keshelava
-
Translational Therapeutics
| Open AccessEstablishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
- L de Plater
- , A Laugé
- & E Marangoni
-
Translational Therapeutics
| Open AccessCombination of temozolomide with immunocytokine F16–IL2 for the treatment of glioblastoma
- M Pedretti
- , C Verpelli
- & L Bello
-
Translational Therapeutics
| Open AccessIntegrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer
- I Garrido-Laguna
- , A C Tan
- & M Hidalgo
-
Translational Therapeutics
| Open AccessTrastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma model
- J-P Delord
- , S Quideau
- & B C Allal